{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-20254 Clostridium difficile policy 1.1.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "POLICY FOR THE CONTROL AND MANAGEMENT OF CLOSTRIDIOIDES DIFFICILE (C DIFFICILE)"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-20254"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.1"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "22 December 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "21 December 2023"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "National Guidance/Recommendations"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Harm Free Care"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Emma Dowling, Head of Nursing Infection Prevention and Control MSE"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Basildon Hospital IPCC Broomfield Hospital IPCC Southend Hospital IPCC"
                    },
                    {
                        "text": "15 October 2020 15 October 2020 15 October 2020"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dawn Patience, Director Harm Free Care"
                    },
                    {
                        "text": "15 October 2020"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "15 December 2020"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group)"
                    },
                    {
                        "text": "January 2020"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet \u2612 Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-20254 Clostridium difficile policy 1.1.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Edith Mahachi"
                    },
                    {
                        "text": "Site Lead Nurse Infection Control BTUH"
                    },
                    {
                        "text": "15 October 2020"
                    },
                    {
                        "text": "Judy Holdsworth"
                    },
                    {
                        "text": "Site Lead Nurse Infection Control MEHT"
                    },
                    {
                        "text": "15 October 2020"
                    },
                    {
                        "text": "Dr Awad-El-Kariem"
                    },
                    {
                        "text": "Consultant Microbiologist /DIPC BTUH"
                    },
                    {
                        "text": "15 October 2020"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Infection Control Committee SUHFT"
                    },
                    {
                        "text": "15 October 2020"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Infection Control Committee BTUH"
                    },
                    {
                        "text": "15 October 2020"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Infection Control Committee MEHT"
                    },
                    {
                        "text": "15 October 2020"
                    },
                    {
                        "text": "Titi Odewumi"
                    },
                    {
                        "text": "Lead Antimicrobial Pharmacist MSE"
                    },
                    {
                        "text": "19 October 2020"
                    },
                    {
                        "text": "Dr John Day"
                    },
                    {
                        "text": "Consultant Infectious Diseases/Infection Control Doctor SUHFT"
                    },
                    {
                        "text": "20 October 2020"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Decontamination Policy or equivalent Isolation Policy or equivalent Hand Decontamination Policy or equivalent Outbreak Policy or equivalent Empiric Antibiotic Guidelines for Critical Care Patients Adults or equivalent Empiric Antibiotic Guidelines for the Accident and Emergency Dept or equivalent Empiric Antibiotic Guidelines for Paediatric Patients or equivalent Empiric Antimicrobial Guidelines for Obstetrics & Gynaecology or equivalent"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 6,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/ Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "22 December 2020"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "1.2"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "Appendix 2 amended, extension phone numbers removed."
                    },
                    {
                        "text": "22 June 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 7
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust ........................................................................ 6"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Management of patients with Clostridioides difficile diarrhoea ..................................... 7"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Infection control precautions ....................................................................................... 10"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Training Requirements ............................................................................................... 15"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Monitoring and Audit ................................................................................................... 15"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Approval and Implementation ..................................................................................... 16  Equality Impact Assessment ....................................................................................... 16  References ................................................................................................................. 16 Appendix 1: Bristol Stool Chart .......................................................................................... 18 Appendix 2 Special measures ........................................................................................... 20 Appendix 3 \u2013 Alert Sheet ................................................................................................... 21 Appendix 4: Preliminary Equality Analysis ......................................................................... 22"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "Clostridioides difficile is a bacterium of the Peptostreptococcaceae family, a group of Gram-positive, anaerobic bacilli which is widely found in soil and in the intestinal gut of animals. When exposed to unfavourable conditions, C. difficile bacteria can form spores which are resistant to drying, heat, stomach acid, alcohol and can survive in the environment for long periods of time. These factors facilitate the transmission of C.difficile spores from infected patients and may contaminate the environment, which allows transmission of infection to other vulnerable patients (HPA 2006)."
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "The principle route of transmission is via faecal-oral spread. This may occur directly by close contact with symptomatic patients or more commonly indirect spread from a contaminated environment or via objects such as medical equipment in hospital setting."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "C.difficile is found in two thirds of babies, without causing symptoms. Asymptomatic carriage can also be seen in 3-5% of adults. However, the rate of colonisation increases to 10-20% in the elderly, especially if they have been in contact with healthcare facilities."
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "Factors which increase the risk of C difficile infection (CDI) include antibiotic treatment, age 65 or over and underlying morbidity such as, abdominal surgery, cancer, chronic renal disease and enteral feeding (HPA 2006). Antimicrobials suppress other gut bacteria allowing C.difficile to proliferate and produce toxins resulting in CDI (DH 2008). Any antibiotic may be associated with CDI but broad spectrum antibiotics, such as cephalosporins and fluoroquinolones are most often linked."
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to provide guidance on the management, prevention and control of Clostridium difficile infections (CDI) within the MSE NHS Foundation Trust, which is a requirement of all NHS Trusts under The Health and Social Care Act 2008 (HMSO, 2008) and Department of Health (2008) Clostridium difficile Infection. \u2018How to Deal with the problem' (HPA/DH 2009)."
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "The objectives of this policy are to:"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reduce the incidence and prevent any avoidable causes of CDI within SGH"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Standardise and improve the clinical and nursing management of CDI"
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Produce an evidence-based policy, reflecting National guidelines"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Adherence to this guidance will ensure compliance with Care Quality Commission (CQC) registration requirement for cleanliness and infection control (CQC Guidance about compliance, Outcome 8) (HMSO, 2008) and criterion 6 of The Code of Practice: The Health and Social Care Act (DH, 2009)"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "type": "table",
            "sequence_num": 30,
            "data": {
                "num_rows": 21,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "Clostridioides difficile (C difficile, C diff ) case"
                    },
                    {
                        "text": "One episode of diarrhoea (Bristol Stool Chart type 5-7) that is not attributable to any other cause, with a positive toxin assay."
                    },
                    {
                        "text": "CDI"
                    },
                    {
                        "text": "Clostridioides difficile infection"
                    },
                    {
                        "text": "GDH"
                    },
                    {
                        "text": "Glutamate dehydrogenase"
                    },
                    {
                        "text": "Endotoxin"
                    },
                    {
                        "text": "A toxin that is not secreted in soluble form by live bacteria, but is a structural component in the bacteria which is released mainly when bacteria are destroyed."
                    },
                    {
                        "text": "Pseudo- membranous colitis"
                    },
                    {
                        "text": "Is an infection of the colon, frequently, but not exclusively caused by Clostridioides difficile In severe cases life-threatening complications, such as toxic mega-colon, can occur."
                    },
                    {
                        "text": "Toxic mega colon"
                    },
                    {
                        "text": "A life-threatening complication of intestinal conditions. It is characterized by a very dilated colon (megacolon), accompanied by abdominal distension (bloating), sometimes fever, abdominal pain, or shock may be found."
                    },
                    {
                        "text": "DIPC"
                    },
                    {
                        "text": "Director Infection Prevention and Control."
                    },
                    {
                        "text": "DoH"
                    },
                    {
                        "text": "Department of Health"
                    },
                    {
                        "text": "IPCT"
                    },
                    {
                        "text": "Infection Prevention and Control Team."
                    },
                    {
                        "text": "IPCC"
                    },
                    {
                        "text": "Infection Prevention and Control Committee."
                    },
                    {
                        "text": "IPCN"
                    },
                    {
                        "text": "Infection Prevention and Control Nurse."
                    },
                    {
                        "text": "HCAI"
                    },
                    {
                        "text": "Health Care Associated Infection"
                    },
                    {
                        "text": "HPV"
                    },
                    {
                        "text": "Hydrogen Peroxide Vapour"
                    },
                    {
                        "text": "PCT"
                    },
                    {
                        "text": "Primary Health Care Trust"
                    },
                    {
                        "text": "PII"
                    },
                    {
                        "text": "Period of Increased Incidence"
                    },
                    {
                        "text": "SUH"
                    },
                    {
                        "text": "Southend University Hospital"
                    },
                    {
                        "text": "SI"
                    },
                    {
                        "text": "Serious Incident"
                    },
                    {
                        "text": "DATIX"
                    },
                    {
                        "text": "Incident and near miss reporting form"
                    },
                    {
                        "text": "CQC"
                    },
                    {
                        "text": "Care Quality Commission"
                    },
                    {
                        "text": "SIGHT"
                    },
                    {
                        "text": "Mnemonic protocol when managing patients with suspected infectious diarrhoea"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role and responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Duties within the Trust (Committees)"
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "Infection Prevention and Control Committee (IPCC) is responsible for the review of this policy at least every two years, but more frequently if there are changes to Infection Prevention and Control Legislation or guidance."
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "Duties of Individuals within Trust"
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.4,
                "text": "The Chief Executive has overall responsibility for the implementation of this policy. The Chief Executive delegates this responsibility to the Director for Infection Prevention and Control."
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.5,
                "text": "The Director for Infection Prevention and Control (DIPC) has the responsibility to ensure there are adequate resources available to manage infection prevention and control within Southend University NHS Trust"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.6,
                "text": "Consultant Microbiologist/Infection Control Doctor. To work with the Director of Infection Prevention and Control to deliver the Trust's annual infection control agenda. Clinical lead for overseeing, providing advice on and implementation of infection control practices across the Trust."
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.7,
                "text": "Infection Prevention and Control Team (IPCT) responsibilities are to:"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Promote evidence-based infection prevention and control practices in line with Trust policies."
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Be responsible for the production of the policy and management procedures"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Liaise with the Occupational Health Department at SGHFT in the screening of staff if screening is required."
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "Antimicrobial pharmacist and ward pharmacists:"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitor the use of antimicrobial agents within the Trust and feedback on areas for improvement."
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Daily review of prescription charts by ward pharmacists to check compliance with antibiotic guidelines and to discuss deviations with the ward or prescribing doctor."
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.9,
                "text": "Consultant and other medical staff responsibilities: Use antibiotics prudently and according to the Antibiotic Prescribing Policy. Review antibiotic prescriptions on a daily basis on ward rounds, amending treatment according to clinical response and culture results, stopping unnecessary prescriptions, changing those that do not comply with the current Antibiotic Policy or reviewing medication that exacerbate CDI."
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Commence treatment of patients with confirmed CDI in accordance with this policy or Microbiology advice."
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Participate in Post  Infection Review (PIR)  investigations to learn lessons  and implement best practice."
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure that all patients with CDI are kept under review by Microbiology and other specialists with an interest in Clostridioides difficile"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure Clostridioides difficile included on death certificate if causes or contributes to patients' death."
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Occupational Health Department have responsibility to:"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Screen and monitor staff as clinically necessary"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appropriate management of care of staff members"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.11,
                "text": "Divisions:"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy implementation assurance will be checked by reviewing audit results undertaken by the Infection Prevention and Control Team (IPCT) and Ward Staff."
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Any deficits identified will be addressed immediately to facilitate compliance with policy."
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.12,
                "text": "On-call Managers"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Are responsible for providing senior and executive leadership to ensure implementation of this policy, and for ensuring infection risks are fully considered and documented when complex decisions need to be made regarding capacity and patient flow."
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.13,
                "text": "Employees have the responsibility to:"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Adhere to this policy and procedures"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Attend relevant training as appropriate to their individual role"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Participate in any relevant audit as part of the Infection Prevention and Control Audit Programme"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Identify to their line manager any problems or failings associated with the management of Clostridioides difficile"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Promptly report all incidents concerning the risks or exposure to Clostridioides difficile in accordance with the Trust's Incident Reporting Policy"
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Management of patients with Clostridioides difficile diarrhoea"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.1,
                "text": "Clinical features"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The illness ranges from mild self-limiting diarrhoea to explosive watery and foul smelling diarrhoea."
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Symptoms are often associated with antibiotic therapy."
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The patient may also have fever and abdominal cramps."
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Occasionally Clostridioides difficile can lead to potentially fatal pseudo membranous colitis and perforation of the bowel."
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.2,
                "text": "Definition of diarrhoea One episode of diarrhoea, defined either as stool loose enough to take the shape of a container used to sample it or as Bristol Stool Chart types 5\u20137 that is not attributable to any other cause, including laxatives, and is not usual for the individual."
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Who is classed as infected?"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The patient is symptomatic i.e. has diarrhoea and stool tests positive for Clostridioides difficile (and all other potential causes for diarrhoea have been excluded) Please refer to section 5.5 for more detail."
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The patient has a high white blood cell count and ileus with a background history of Clostridioides difficile or diarrhoea prior to the ileus."
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The colonoscopy is compatible with pseudomembranous colitis."
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.4,
                "text": "Initial Management of Patients"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Clinicians (doctors and nurses) should apply the following mnemonic protocol (SIGHT) when managing patients with suspected infectious diarrhoea:"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "type": "table",
            "sequence_num": 77,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "S"
                    },
                    {
                        "text": "Suspect that a case may be infective that is not attributable to any other cause. One episode of diarrhoea (Bristol Stool Chart type 5-7)."
                    },
                    {
                        "text": "I"
                    },
                    {
                        "text": "Isolate the patient and consult with the infection prevention and control team (IPCT) while determining the cause of the diarrhoea."
                    },
                    {
                        "text": "G"
                    },
                    {
                        "text": "Gloves and aprons must be used for all contacts with the patient and their environment, with chlorine used for all cleaning."
                    },
                    {
                        "text": "H"
                    },
                    {
                        "text": "Hand washing with soap and water should be carried out before and after each contact with the patient and the patient's environment."
                    },
                    {
                        "text": "T"
                    },
                    {
                        "text": "Test the stool for toxin, by sending a specimen immediately (after isolating the patient)."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The  patient  should  be  managed  according  to  Clinical  Guidelines  for  the management of Clostridium difficile associated diarrhoea available on the local intranet site."
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.5,
                "text": "Suspected Infectious Diarrhoea:"
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Although  C  difficile  infection  (CDI)  is  a  well-recognized  cause  of  antibiotic- associated diarrhoea, other infectious causes should also be considered e.g. viral, campylobacter, salmonella."
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.6,
                "text": "CDI should be suspected in patients with diarrhoea in the following situations:"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The patient is on or has been on antibiotics in the past 3 months"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "There is explosive, watery, offensive diarrhoea, fever, bloody stools or severe abdominal cramps"
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The patient has previously tested positive for C difficile"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The patient developed diarrhoea on a ward where there is or was a known case of CDI"
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.7,
                "text": "Diagnosis of Clostridioides difficile  infection (CDI)"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.1 Only test stools from symptomatic patients, i.e. only liquid/loose stools that take the shape of the container (Bristol Stool Chart types 5\u20137)."
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.2 In suspected cases of \u2018silent' CDI, such as ileus, toxic megacolon or pseudomembranous colitis without diarrhoea, other diagnostic procedures, such as colonoscopy, white cell count (WCC), serum creatinine and abdominal CT (computerised tomography) scanning, may be required."
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.3 It is essential to document the date and time that a specimen has been taken in order to avoid unnecessary and costly repeats."
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.4 Do not retest for C. difficile toxin (CDT) positive cases if patients are still symptomatic within a period of 28 days unless symptoms resolve and then recur and there is a need to confirm recurrent CDI \u2013 discuss with IPCT/Consultant Microbiologist"
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.5 There is no need to submit further samples to establish when the patient is no longer infectious once they have been identified as being CDI toxin positive, this should be determined by the clinical picture e.g. asymptomatic for >48hrs"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.6 There is no need to have a negative stool sample prior to patients being transferred to care homes or other institutions"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.7 Clostridioides difficile infection occurs when the normal bacterial flora in the bowel is altered allowing Clostridioides difficile to proliferate and produce toxin A and /or"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.8 As recommended by the DoH, the Trust uses a 2 part testing process to identify Clostridioides difficile carriage."
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.9 If the first test for Glutamate dehydrogenase (GDH) is negative it means that Clostridioides difficile is not present in the gut at the time of testing. If the GDH test is positive, then the sample will be tested for the presence of Clostridioides difficile toxin."
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.7.10 If only the GDH test is positive this indicates that Clostridioides difficile is present in the gut but is not producing toxin so other reasons for diarrhoea need to be sought. Please refer to section 5.5 for the management of these patients that are GDH positive and symptomatic (i.e. loose stools) as it should be assumed that they could potentially be excreting spores."
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.11 If both the GDH and toxin test are positive in a patient whose diarrhoea cannot be attributed to other causes this is indicative of Clostridioides difficile infection (CDI)."
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.12 No test or combination of tests is infallible and the clinical condition of the patient should always be taken into consideration when making management choices."
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Clinical judgment must be used when considering treating if clinical suspicion is high despite a toxin negative result."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.7.13 Patients who present with a GDH +ve sample but continue to have diarrhoea may be retested, please discuss all cases with the Infection Prevention and Control Team or consultant microbiologist. These patients MUST be isolated until symptom free for >48 hours."
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.8,
                "text": "Risk factors"
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Those most at risk are people who have recently been treated with broad spectrum antibiotics:"
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Elderly (over 65)"
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Immunosuppressed"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Enteral / naso-gastric feeding"
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Non-surgical gastro-intestinal procedures e.g. endoscopy"
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Administration of Proton Pump Inhibitors (PPI's)"
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Intensive care treatment"
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Frequent hospital admissions"
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Please note: Although most commonly acquired in hospital, Clostridioides difficile can be a community acquired infection."
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.9,
                "text": "Transmission"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Transmission is via spores that survive in faecal matter. These spores are resistant to heat and alcohol."
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Clostridioides difficile  is easily transmitted between patients on the hands of healthcare workers or in the hospital environment."
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Contamination of patient equipment such as commodes, cot sides, chairs and bathroom facilities will increase the risk of an infection being spread."
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Infection control precautions"
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.1,
                "text": "Patient Management"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 1,
                "text": "If a patient presents with unexplained diarrhoea, they must be isolated in a single room and a Bristol Stool chart commenced. If Clostridioides difficile is suspected obtain a stool sample immediately and send to the microbiology laboratory and request Clostridioides difficile toxin. The specimen pot must be at least \u00bc full."
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.1 Patients must be isolated in a single room within 2 hours of C difficile infection being suspected. The vacated bed space must be terminally cleaned by Cleaning Response Team and curtains changed (contact via switchboard);"
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.2 Single rooms with en-suite facilities are preferable. Patients who do not have access to en-suite facilities must have a commode dedicated for their own use only."
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.3 All commodes must be cleaned thoroughly between each patient use using a chlorine based product;"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.4 A \u2018Source Isolation' sign must be placed on the sideroom door, and the door kept closed unless contraindicated by the patients' condition. In such cases the reason must be documented in the patient's medical notes;"
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.5 If a single room is unavailable, cohorting of C difficile patients may be considered by the IPCT;"
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.6 Hands must be washed with soap before patient contact, after removing gloves and /or on leaving the isolation room. Alcohol hand sanitiser is not effective at removing clostridia spores;"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.7 Protective clothing i.e. disposable gloves and apron must be worn for all direct patient contact or when exposure to faeces is anticipated;"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.8 A Trust Bristol Stool Chart must be used for all patients and updated following every bowel action (appendix 1). The consistency/ type of stools should be assessed and recorded using the Bristol Stool Chart Stool chart. Record even if the patient does not have their bowels opened to assess effectiveness of treatment."
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.9 Patients' bed linen and nightwear must be changed daily."
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.10 All hospital linen must be placed in a pink alginate liner and then placed in a white plastic linen bag. Do not leave bags of foul linen in the patient's room. Linen bags must be removed at once. Equipment must be thoroughly cleaned after use or when no longer used using a chlorine based product and a green \u2018I am clean' label attached."
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.11 All clinical waste should be placed in an orange clinical waste bag and handled appropriately."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.12 Any equipment required for patient management / care should ideally be disposable or must be dedicated for that patient only. It should be cleaned after use or when no longer required with a chlorine based product. This includes equipment such as blood pressure cuffs, moving and handling equipment, physiotherapy equipment etc."
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.13 Isolation precautions may be discontinued if the patient has normal stools and has been free from diarrhoea for at least 72 hours. Contact the IPCT for advice."
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.1.14 Air mattresses must be returned to the mattress cleaning service via MEMS for decontamination. The mattresses must be cleaned with choline based product to collection, placed in the plastic bag and a decontamination certificate attached."
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.2,
                "text": "Follow up stool specimens are of no value since the result will often remain positive when patients have recovered symptomatically."
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.3,
                "text": "Action by the Infection Prevention and Control Team:"
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Infection Prevention and Control Team (IPT) receive all positive results for GDH and CDI from the laboratory. The IPT will visit the clinical area to provide"
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 0,
                "text": "verbal and written information to the patient, inform staff and discuss treatment and placement of the patient and appropriate infection control precautions. A C diff alert sheet (appendix 7) will be placed into the patients' clinical record. Patients at Southend Hospital will be offered a C diff alert card (appendix 8)."
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.3.1 The purpose of the card is to make it easier for healthcare providers to identify patients who may be at risk of recurrence/relapse. Patient will be encouraged to show this to any health care professional e.g. dentist, pharmacist community nurse prior to anti biotics being prescribed."
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 1,
                "text": "6.3.2 Root cause analysis (RCA)"
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A RCA must be undertaken for all reported cases of C.difficile plus 48 hours of admission. The investigation must be co-ordinated by the Ward Sister/Charge Nurse with the support of the Infection Prevention and Control Team."
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 1,
                "text": "6.3.3 C .difficile Ward Round"
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In response to the DoH Guidelines the weekly multidisciplinary clinical review of all inpatient C. diff patients within the Trust continues. The review team includes an infection  prevention  and  control  doctor,  Consultant  Gastroenterologist, antimicrobial pharmacist, IPCN, Microbiology Registrar and if possible the patient's own clinician. The objective of the ward round is to ensure that the infection is being treated as a \u2018condition in its own right' to ensure optimum treatment and that the patient is receiving all necessary supportive care."
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "type": "image",
            "sequence_num": 141,
            "data": {
                "url": "MSEPO-20254 Clostridium difficile policy 1.1.003.jpeg"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The C difficile Ward Round sticker shown above is completed by the Consultant Microbiologist during the ward round as a highly visual communication aide."
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.4,
                "text": "Control of Antibiotic usage"
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All prescribers must ensure they avoid unnecessary and inappropriate antibiotic prescribing."
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.5,
                "text": "Outbreak"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.5.1 An outbreak is defined as \u201ctwo or more cases caused by the same strain related in time and place over a defined period that is based on the date of onset of the first  case\u201d (Department of Health 2009). In such cases the IPCT will investigate, an  outbreak meeting will be held and control measures identified."
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "type": "image",
            "sequence_num": 147,
            "data": {
                "url": "MSEPO-20254 Clostridium difficile policy 1.1.004.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.5.2 A period of increased incidence (PII) of Clostridium difficile infection is identified as 2 or more cases, occurring >48 hours post admission, (not relapses) in a 28 day period in ward or department (Department of Health 2009). A PII will necessitate additional  auditing  by  the  IPCT  and  Antimicrobial  Pharmacists,  along  with environmental cleaning and typing of the specimens."
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.5.3 In the event of an outbreak the IPCT carry out an investigation and implement \u2018Special Measures' (Appendix 2)."
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.5.4 The IPCT will monitor the situation with daily updates to the Clinical Site Manager regarding outbreak until it is satisfactorily resolved."
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 1,
                "text": "6.5.5 The Executive Lead / on call will consider if this is declared as a Serious Incident (SI)."
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.6,
                "text": "Visitors and relatives"
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.1 Visitors who are immunocompromised or concerned that they are vulnerable to C.difficile infection should contact the IPCT for individual advice before visiting."
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.2 Visitors need to be aware of the risks of cross infection, the risk to themselves and their responsibilities whilst visiting."
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.3 Visitors are not required to wear protective clothing unless giving / assisting with the patient's personal care."
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.4 Visitors are advised not to eat and drink in the room."
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.5 All visitors should be advised to wash their hands / use Supernova hand sanitiser when leaving the room."
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.6 If visitors are visiting more than one patient, they MUST visit infectious patients last."
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.7,
                "text": "Environmental cleaning"
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.7.1 It is the responsibility of the IPCT to inform the Cleaning Response Team (CRT) that a C difficile isolation room clean is required."
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.7.2 All patients in isolation due to C difficile infection must have their room cleaned by the dedicated C difficile cleaning team on a daily basis using a chlorine dioxide solution."
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.7.3 Once a patient no longer requires isolation, a terminal clean plus HPV machine of the room and toilet is required by the Cleaning Response Team (contact via switchboard)."
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.8,
                "text": "Staff exclusion due to Clostridium difficile"
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.8.1 Staff with diarrhoea should attend their GP for assessment and stool sample."
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.8.2 Staff with diarrhoea, thought to be infective should be excluded from work until they have had a normal bowel habit for 48 hours."
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.9,
                "text": "Transfer"
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.9.1 Patients with C difficile infection should not be transferred to other areas without discussion with the IPCT."
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.9.2 Visits to other departments should be kept to a minimum in order to prevent potential spread of infection. Where visits are necessary, for investigation and treatment patients should not be left in waiting areas with other patients. The patient should return to the ward / unit immediately following the procedure."
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.9.3 When a patient has been positive but symptoms have been resolved, the receiving area should be informed by the transferring ward. This will ensure that the diagnosis of C difficile is considered if the patient has any further diarrhoea."
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.1,
                "text": "Discharge"
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.10.1 Patients should only be discharged to residential care settings when their stool has returned to their normal bowel pattern. Ward staff to complete an Inter-health care Transfer form."
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.10.2 Patients can be discharged to their own home if they still have diarrhoea but are improving and there is no health or social care package in place."
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.10.3 The patient's GP and the residential home, where relevant, will be informed by the IPCT by letter that the patient has been C difficile positive during the admission, so that future antibiotic therapy is appropriate (See example letter appendix 6)."
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.11,
                "text": "C. difficile Deaths"
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If a patient with Clostridioides difficile dies, the death certificate should state whether C difficile was part of the sequence of events leading directly to death or whether it was the underlying cause of death on Part 1 of the certificate. If C difficile was not part of the sequence of events leading directly to death but contributed in some way to it, this should be mentioned in Part 2. Doctors have a legal duty to mention C difficile on a death certificate if it was part of the sequence of events directly leading to death or contributed in some way."
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.12,
                "text": "All CDI deaths that are recorded in part 1 of the death certificate are regarded as a serious incident (SI) and will require reporting on DATIX and an incident form to be raised. This will be investigated at a SI panel to establish the route cause and identify any learning points."
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Also all patients undergoing a colostomy due to CDI will be escalated as a SI)"
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "The training requirements of all staff will be identified through a training needs analysis. Role specific education will be delivered by the service lead or nominated person."
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "It is recommended that Infection Prevention and Control should be included in individual Annual Appraisal and any training needs for IPC addressed."
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Outlined below is the Trust's process of monitoring compliance with, and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "type": "table",
            "sequence_num": 183,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group/Committee/f orum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee/individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Knowledge / compliance and practice in relation to this policy"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "IPCT"
                    },
                    {
                        "text": "as required for each case"
                    },
                    {
                        "text": "IPCC"
                    },
                    {
                        "text": "Site Lead Nurse Infection Prevention and Control"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Approval and implementation"
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "All policies, procedures and guidelines will be approved by the site Infection Prevention and Control Committees, which is the specialist group with the authority to approve MSE Policies. The policy will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "It is the author's responsibility to inform the Director for Harm Free Care of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Equality impact assessment"
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 4)"
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 190
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Commission for Healthcare Audit and Inspection (2005) Management prevention and surveillance of Clostridium difficile interim findings from National Survey of NHS acute trusts in England, Health Protection Agency and Healthcare Commission."
            },
            "type": "ListItem",
            "sequence_num": 191
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Department of Health (2005) Saving Lives: a delivery programme to reduce health care associated infection (HCAI) including MRSA London DH 2005"
            },
            "type": "ListItem",
            "sequence_num": 192
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Department of Health (2007) High Impact Intervention No 7. Care bundle to reduce the risk from Clostridium difficile"
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Department of Health. The Health and Social Care Act 2012. Code of Practice for the NHS on the prevention and control of healthcare associated infections and related guidance."
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Department of Health and HPA (2008) Clostridium difficile infection: How to deal with the problem. London. Department of Health."
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "data": {
                "is_heading": 0,
                "text": "HPA (2006) Clostridium difficile: Findings and recommendations from a review of the epidemiology and a survey of Directors of Infection Prevention and Control in England. London. Health Protection Agency."
            },
            "type": "ListItem",
            "sequence_num": 196
        },
        {
            "data": {
                "is_heading": 0,
                "text": "PL/CMO/2005/6, PLCMO2005/5 Gateway No. 5954 (2005). Infection caused by Clostridium difficile, Department of Health."
            },
            "type": "ListItem",
            "sequence_num": 197
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Surawicz C M; Brandt L J et al. (2013). Guidelines for Diagnosis, Treatment and Prevention of Clostridium difficile Infections. Am J Gastroenterology 2013; 108:4"
            },
            "type": "ListItem",
            "sequence_num": 198
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Bristol Stool Chart"
            },
            "type": "ListItem",
            "sequence_num": 199
        },
        {
            "type": "image",
            "sequence_num": 200,
            "data": {
                "url": "MSEPO-20254 Clostridium difficile policy 1.1.005.jpeg"
            }
        },
        {
            "type": "image",
            "sequence_num": 201,
            "data": {
                "url": "MSEPO-20254 Clostridium difficile policy 1.1.006.jpeg"
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Special measures"
            },
            "type": "ListItem",
            "sequence_num": 202
        },
        {
            "data": {
                "is_heading": 0,
                "text": "C difficile Special Measures"
            },
            "type": "ListItem",
            "sequence_num": 203
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Ward \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026   Date \u2026\u2026\u2026\u2026\u2026..."
            },
            "type": "ListItem",
            "sequence_num": 204
        },
        {
            "type": "table",
            "sequence_num": 205,
            "data": {
                "num_rows": 14,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Action"
                    },
                    {
                        "text": "Completed by:"
                    },
                    {
                        "text": "Completed when:"
                    },
                    {
                        "text": "Infection Prevention Team will inform the Clinical Lead, Head of Nursing ,Matron, Ward Manager, and Domestic Supervisor of special measures in place via e mail"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "The Ward Manager and/or Infection Prevention link nurse/IPCN will conduct daily C.difficile Policy audits for one week"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "The Ward Manager and/or Infection Prevention link nurse will conduct daily HHOT audits for a week"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "The IPCN will complete a timeline of events associated with the period of increased incidence(PPI)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "There will be a weekly C diff ward round on the ward"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "The IPCN will provide light box hand hygiene training on the ward"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "The IPCN will conduct daily PPE, isolation room and environment checks"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "The domestic staff will clean the ward as per Decontamination Policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "There will be PCR ribotyping of the isolates"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "The Ward Manager will be responsible for completing an action plan and providing evidence that actions are completed"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "The DIPC /IPCN will arrange a Special Measures meeting if required"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "At the end of one week of Special Measures, the IPCN / DIPC will review the ward and determine whether a second week is required"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "All periods of increased incidence and actions taken will be reported to the monthly Infection Prevention and Control Committee"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 3 \u2013 Alert Sheet"
            },
            "type": "ListItem",
            "sequence_num": 206
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This is an example site specific alerts are available at each site."
            },
            "type": "ListItem",
            "sequence_num": 207
        },
        {
            "type": "image",
            "sequence_num": 208,
            "data": {
                "url": "MSEPO-20254 Clostridium difficile policy 1.1.007.jpeg"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy for the control and management of clostridioides difficile (C difficile) /MSEPO-20254/1.1"
            },
            "type": "ListItem",
            "sequence_num": 209
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 210
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy for the control and management of clostridioides difficile (C difficile) /MSEPO-20254/1.1"
            },
            "type": "ListItem",
            "sequence_num": 211
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 4: Preliminary equality analysis"
            },
            "type": "ListItem",
            "sequence_num": 212
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Policy for the control and management of clostridioides difficile (C difficile) /MSEPO-20254 (please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 213
        },
        {
            "type": "table",
            "sequence_num": 214,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 215,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "To make three separate policies into one"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "To ensure a consistent approach across the MSE"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Everyone as this is a uniform approach"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to page 1 and 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 216,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Head of Infection Prevention and Control"
                    },
                    {
                        "text": "08 December 2020"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 217
        }
    ]
}